Department of Preventive Medicine, Chungnam National University College of Medicine, Daejeon, South Korea.
Public Health Medical Service, SMG-SNU Boramae Medical Center, Seoul, South Korea.
Allergol Int. 2019 Jan;68(1):52-58. doi: 10.1016/j.alit.2018.05.011. Epub 2018 Jun 23.
Previous epidemiologic studies of the natural course of urticaria mainly focused on chronic spontaneous urticaria and were conducted at hospitals. The natural course of new-onset urticaria in the general population is unknown.
Patients with new-onset urticaria were identified from the National Health Insurance Service-National Sample Cohort data. Patients who had at least one visit for urticaria in 2002 and 2003 were excluded and the study cohort consisted of 1,027,620 subjects with no history of urticaria. We analyzed cumulative incidences of urticaria, chronic urticaria, and chronic urticaria remission using the life table estimation method from 2004 to 2013. Their association with related factors was analyzed using the Cox proportional hazards analysis.
From 2004 to 2013, a total of 49,129 patients with new-onset urticaria were identified. The 10-year cumulative incidence rate of urticaria for the general population was 4.9% and that of chronic urticaria among patients with new-onset urticaria was 7.8%. Remission rates of chronic urticaria were 52.6% at 1 year and 88.9% at 5 years. Age, sex, residential area, and autoimmune thyroid disease were significantly associated with urticaria or chronic urticaria, but not with chronic urticaria remission, after adjusting for covariates. Female individuals were more likely to have new-onset urticaria but less likely to develop chronic urticaria compared with male individuals.
During the 10-year follow-up period, only a small proportion of patients with new-onset urticaria developed chronic urticaria. Remission was achieved in the majority of patients with chronic urticaria regardless of demographic characteristics or accompanying thyroid disease.
之前有关荨麻疹自然病程的流行病学研究主要集中在慢性自发性荨麻疹上,且都是在医院进行的。普通人群中新发性荨麻疹的自然病程尚不清楚。
从国民健康保险服务-国家样本队列数据中确定新发荨麻疹患者。排除 2002 年和 2003 年至少有一次荨麻疹就诊的患者,研究队列包括 1027620 例无荨麻疹病史的患者。我们使用寿命表估计法分析了 2004 年至 2013 年期间的荨麻疹、慢性荨麻疹和慢性荨麻疹缓解的累积发生率。使用 Cox 比例风险分析分析了它们与相关因素的关系。
从 2004 年至 2013 年,共确定了 49129 例新发荨麻疹患者。普通人群的 10 年累积荨麻疹发生率为 4.9%,新发荨麻疹患者中慢性荨麻疹的发生率为 7.8%。慢性荨麻疹的缓解率在 1 年内为 52.6%,在 5 年内为 88.9%。调整了协变量后,年龄、性别、居住地区和自身免疫性甲状腺疾病与荨麻疹或慢性荨麻疹显著相关,但与慢性荨麻疹缓解无关。与男性相比,女性更易发生新发荨麻疹,但发展为慢性荨麻疹的可能性较小。
在 10 年的随访期间,只有一小部分新发荨麻疹患者发展为慢性荨麻疹。无论患者的人口统计学特征或伴随的甲状腺疾病如何,大多数慢性荨麻疹患者都能缓解。